Ph.D., Vice President Research & Development, CareDx
Dr. Woodward joined CareDx in 2001 to apply genomics to the field of transplantation; ultimately developing AlloMap, now an integral component of precise heart transplant patient care. Most recently the team at CareDx launched AlloSure, a cell-free DNA test that is applicable across the spectrum of solid organ transplantation.
Presentation Title and Company Description
Clinical Dx Showcase: New Era for Precision Transplant Surveillance
CareDx, Inc. is a global molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions supported with high quality evidence for patient management across the pre- and post-transplant continuum.